ANBIO BIOTECHNOLOGY LTD (NNNN) Stock Price & Overview
NASDAQ:NNNN • KYG0367B1059
The current stock price of NNNN is 22.54 USD. Today NNNN is up by 2.88%. In the past month the price decreased by -17.01%. In the past year, price increased by 215.25%.
NNNN Key Statistics
- Market Cap
- 989.281M
- P/E
- 161.00
- Fwd P/E
- N/A
- EPS (TTM)
- 0.14
- Dividend Yield
- N/A
NNNN Stock Performance
NNNN Stock Chart
NNNN Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to NNNN. When comparing the yearly performance of all stocks, NNNN is one of the better performing stocks in the market, outperforming 96.86% of all stocks.
NNNN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to NNNN. NNNN gets an excellent profitability rating and is at the same time showing great financial health properties.
NNNN Earnings
NNNN Forecast & Estimates
NNNN Groups
Sector & Classification
NNNN Financial Highlights
Over the last trailing twelve months NNNN reported a non-GAAP Earnings per Share(EPS) of 0.14. The EPS increased by 47.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 42.53% | ||
| ROA | 31.55% | ||
| ROE | 34.72% | ||
| Debt/Equity | 0 |
NNNN Ownership
NNNN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.19 | 402.577B | ||
| AMGN | AMGEN INC | 16.11 | 203.574B | ||
| GILD | GILEAD SCIENCES INC | 16.43 | 181.247B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 24.66 | 125.079B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.97 | 81.897B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.52 | 42.495B | ||
| INSM | INSMED INC | N/A | 30.048B | ||
| BIIB | BIOGEN INC | 11.5 | 27.955B | ||
| NTRA | NATERA INC | N/A | 27.865B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.84 | 23.875B | ||
| MRNA | MODERNA INC | N/A | 22.105B | ||
| EXAS | EXACT SCIENCES CORP | 339.75 | 19.738B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.736B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NNNN
Company Profile
Anbio Biotechnology is a medical device company. The company is headquartered in Frankfurt, Hessen and currently employs 27 full-time employees. The company went IPO on 2025-02-19. The firm is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
Company Info
IPO: 2025-02-19
ANBIO BIOTECHNOLOGY LTD
Friedrich-Ebert-Anlage 49
Frankfurt HESSEN DE
Employees: 27
Phone: 4916096247281
ANBIO BIOTECHNOLOGY LTD / NNNN FAQ
Can you describe the business of ANBIO BIOTECHNOLOGY LTD?
Anbio Biotechnology is a medical device company. The company is headquartered in Frankfurt, Hessen and currently employs 27 full-time employees. The company went IPO on 2025-02-19. The firm is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
What is the current price of NNNN stock?
The current stock price of NNNN is 22.54 USD. The price increased by 2.88% in the last trading session.
What is the dividend status of ANBIO BIOTECHNOLOGY LTD?
NNNN does not pay a dividend.
What is the ChartMill rating of ANBIO BIOTECHNOLOGY LTD stock?
NNNN has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Which stock exchange lists NNNN stock?
NNNN stock is listed on the Nasdaq exchange.
What is the employee count for NNNN stock?
ANBIO BIOTECHNOLOGY LTD (NNNN) currently has 27 employees.
Can you provide the ownership details for NNNN stock?
You can find the ownership structure of ANBIO BIOTECHNOLOGY LTD (NNNN) on the Ownership tab.